MedPath

GLEOLAN

These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN™ (aminolevulinic acid hydrochloride) for oral solutionInitial U.S. Approval: [1999]

Approved
Approval ID

cdeded66-0017-42cf-9471-13f231014323

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 4, 2021

Manufacturers
FDA

NX DEVELOPMENT CORP

DUNS: 079994320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

AMINOLEVULINIC ACID HYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code71469-231
Application NumberNDA208630
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateFebruary 15, 2019
Generic NameAMINOLEVULINIC ACID HYDROCHLORIDE

INGREDIENTS (1)

AMINOLEVULINIC ACID HYDROCHLORIDEActive
Quantity: 1500 mg in 1 1
Code: V35KBM8JGR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLEOLAN - FDA Drug Approval Details